TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,160 | -40.3% | 11,258 | -36.4% | 0.00% | -50.0% |
| Q2 2023 | $291,744 | 0.0% | 17,703 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $291,744 | +38.2% | 17,703 | +30.9% | 0.00% | +100.0% |
| Q4 2022 | $211,036 | +2.4% | 13,528 | -15.2% | 0.00% | 0.0% |
| Q3 2022 | $206,000 | -9.6% | 15,954 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $228,000 | -10.6% | 16,336 | -8.8% | 0.00% | 0.0% |
| Q1 2022 | $255,000 | +8.5% | 17,915 | +3.5% | 0.00% | 0.0% |
| Q4 2021 | $235,000 | -39.3% | 17,314 | -27.0% | 0.00% | -50.0% |
| Q3 2021 | $387,000 | +1.6% | 23,726 | +4.3% | 0.00% | 0.0% |
| Q2 2021 | $381,000 | +50.6% | 22,737 | +63.4% | 0.00% | +100.0% |
| Q1 2021 | $253,000 | +39.8% | 13,913 | +36.8% | 0.00% | 0.0% |
| Q3 2020 | $181,000 | +18.3% | 10,169 | +18.5% | 0.00% | 0.0% |
| Q2 2020 | $153,000 | -27.5% | 8,580 | -20.2% | 0.00% | 0.0% |
| Q1 2020 | $211,000 | 0.0% | 10,750 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $211,000 | +20.6% | 10,750 | +4.7% | 0.00% | 0.0% |
| Q3 2019 | $175,000 | -3.3% | 10,270 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $181,000 | -96.1% | 10,320 | -95.5% | 0.00% | -95.2% |
| Q1 2019 | $4,672,000 | +27.4% | 229,434 | +5.2% | 0.02% | +16.7% |
| Q4 2018 | $3,667,000 | -53.8% | 218,085 | -41.2% | 0.02% | -43.8% |
| Q3 2018 | $7,938,000 | +1.9% | 370,991 | +0.6% | 0.03% | -5.9% |
| Q2 2018 | $7,791,000 | +8959.3% | 368,960 | +11894.8% | 0.03% | – |
| Q1 2018 | $86,000 | 0.0% | 3,076 | 0.0% | 0.00% | – |
| Q4 2017 | $86,000 | +48.3% | 3,076 | +42.9% | 0.00% | – |
| Q3 2017 | $58,000 | +176.2% | 2,153 | +128.1% | 0.00% | – |
| Q2 2017 | $21,000 | 0.0% | 944 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | +75.0% | 944 | +46.6% | 0.00% | – |
| Q4 2016 | $12,000 | -29.4% | 644 | -15.3% | 0.00% | – |
| Q3 2016 | $17,000 | +30.8% | 760 | +19.1% | 0.00% | – |
| Q2 2016 | $13,000 | -71.1% | 638 | -68.4% | 0.00% | – |
| Q1 2016 | $45,000 | +32.4% | 2,018 | +42.9% | 0.00% | – |
| Q4 2015 | $34,000 | -94.0% | 1,412 | -94.5% | 0.00% | -100.0% |
| Q3 2015 | $563,000 | -8.0% | 25,875 | +1.8% | 0.00% | 0.0% |
| Q2 2015 | $612,000 | -2.4% | 25,418 | +1.2% | 0.00% | -20.0% |
| Q1 2015 | $627,000 | +21.0% | 25,109 | +0.7% | 0.01% | +25.0% |
| Q4 2014 | $518,000 | +350.4% | 24,929 | +369.2% | 0.00% | +300.0% |
| Q3 2014 | $115,000 | +1542.9% | 5,313 | +1529.8% | 0.00% | – |
| Q1 2014 | $7,000 | 0.0% | 326 | 0.0% | 0.00% | – |
| Q4 2013 | $7,000 | – | 326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |